This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
# Preservation Solutions and Devices Providers
# Life Sciences Companies
# Medical Device Manufacturers
# Market Research and Consulting Firms
# Healthcare Service Providers
# Medical Research Institutes
# Regulatory Bodies
# Venture Capitalists
Find More Details | Download PDF Brochure@
Factors Influencing Global Growth:-
The growth of the overall market can be contributed to rising multi-organ failure cases in aging population, technological advancements, increasing government initiatives to promote organ donation and rising number of solid-organ transplant procedures.
# High Cost of Organ Transplantation
# Normothermic Machine Perfusion: A New Paradigm for Organ Preservation
# Significant Gap between Number of Organs Donated and Organs Required Annually
# Limited Medical Reimbursements for Organ Donation and Transplantation
Monetary Growth Expectations, Globally:
According to the Research Study conducted by MarketsandMarkets™: This report studies the global organ preservation market for the forecast period of 2016 to 2021. The market is expected to reach USD 241.2 Million by 2021 from USD 165.9 Million in 2016 at a CAGR of 7.8% during the forecast period.
Geographical Growth Scenario:
On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the organ preservation market. Its large share can be attributed to growing cases of kidney failure, rising organ transplants, favorable reimbursements scenario within some provinces in Canada, and novel technological advancements by U.S. players.
However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period due to the new regulatory framework in China, and increasing organ donations in Asia-Pacific and serve as a revenue pocket for companies offering organ preservation solutions and transport systems
Request Sample Pages@
Leading Market Players:
# Organ Recovery Systems (U.S.)
# Xvivo Perfusion AB (Sweden)
# Essential Pharmaceuticals LLC (U.S.)
# Dr. Franz Kohler Chemie GmbH (Germany)
# Waters Medical Systems LLC (U.S.) and many more…
Client acquisitions, approvals & certifications, market expansions, and other (product launches and integrations, agreements, and contracts) are the major developments undertaken by the players to achieve growth in this market. Client acquisitions accounted for ~41% of the total developments undertaken by the players in this market. Some of the significant client acquisitions have been experienced by Lifeline Scientific, Inc. (U.S.) and Transmedics, Inc., (U.S.) OrganOx, Ltd. (U.K), Organ Assist (Netherlands) and Hibernicor LLC (U.S.).
Approvals & Certifications accounted for ~38% of the total key developments in the market from January 2013 to May 2016. Paragonix Technolgies, Inc. (U.S.), Lifeline Scientific, Inc. (U.S.), OrganOx, Ltd. (U.K), Organ Assist (Netherlands) and Dr. Franz Kohler Chemie GmbH (Germany) were the key players that carried out these developments. One of the significant approvals was witnessed by Lifeline Scientific, Inc. from China’s Food and Drug Administration (CFDA) approving LifePort Kidney Transporter.
Market expansions accounted for ~9% of the total key developments in the organ preservation market between January 2013 and May 2016. Hemarina SA (France), Lifeline Scientific, Inc. (U.S.), and Dr. Franz Kohler Chemie GmbH (Germany) were the key players that carried out these developments. Players adopted this strategy to strengthen their networks, increase their global presence, enhance customer experience, and improve relationships with customers.
You Can Also Read the Detailed Article on “Organ Preservation Market – Analysis & Forecasts to 2021”, Here..!